Evaluating Mikhail Blagosklonny’s Impressive Career

Mikhail Blagosklonny is a world-famous oncologist, author, and editor. He has made notable contributions to the overall field of medicine. He currently teaches oncology at Buffalo University’s Roswell Park Cancer Institute, where he is also a board member. Prof. Mikhail earned his M.D and PhD in internal and experimental medicine and cardiology at St. Petersburg’s First Pavlov State Medical University. This heralded the beginning of a highly successful career, which has seen him serve at senior positions in notable institutions such as the Ordway Research Institute and the New York Medical College.

Mikhail’s Research on Aging and Rapamycin

Prof. Mikhail Blagosklonny has led numerous high-profile research teams, which have successfully carried out studies pertaining to the human aging process. At a personal level, he has formulated a premise about the role played by TOR signaling in cancer and aging. This has led him to propose the use of rapamycin, which is a renowned cancer treatment, to slow down the aging process. Mikhail’s hypothesis has been well received within the medical fraternity. He is regarded as one of the most passionate proponents of rapamycin in longevity studies. This has boosted his profile within the fraternity.

Oncotarget

Prof. Mikhail Blagoskloony is best known for being the brains behind Oncotarget, which is a pioneer peer review publication that highlights issues related to oncology research. Oncotarget prides itself in being the most up-to-date open access journal within the medical field, which covers research on aspects related to oncology. Its publisher is Impact Journals. Mikhail established the journal in 2010 and serves as its editor-in-chief alongside Andrei V. Gudkov. The journal is indexed and abstracted in Scopus, the Science Citation Index Expanded, and BIOSIS Previews. This proves its prominence within the medical field.

Read more: Answering the ultimate question “What is the Proximal Cause of Aging?”

Other Editorial Ventures

Besides Oncotarget, Prof. Mikhail is the editor-in-chief of Aging. This is a monthly medical journal that covers the molecular mechanics of the aging process, gerontology, and senescence. He similarly serves in the same position at Cell Death & Differentiation, which is another notable peer reviewed journal. Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249451/

Blagosklonny’s Career Highlights

Mikhail has distinguished himself as a dedicated scientist, more so in the area of aging and cancer research. Mikhail Blagosklonny’s works have been cited by major publications across the world. His breakthrough discoveries have similarly helped to shed light on medical issues that were previously seen to be obscure. Mikhail has been described as a preeminent researcher with a unique understanding of cancer biology and therapy by his peers. His hyper-functionary theory of aging has equally been well received and applauded by peers.

Read works by Mikhail Blagosklonny on Google Scholar